|
|
||||||||
Division of Pulmonary Sciences and Cardiovascular Pulmonary Research Laboratory, University of Colorado Health Sciences Center, Denver, Colorado 80262-0001; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama 35294-0019; and Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110-1010
Nitric oxide (NO) is important in modulating increased pulmonary vascular tone. Whereas in other systems it is believed that the action of NO is mediated through guanosine 3',5'-cyclic monophosphate (cGMP) and protein kinase G (PKG), the validity of this pathway in the pulmonary circulation has not been established. Using isolated salt-perfused normotensive and hypertensive rat lungs, we studied the effects of the soluble guanylyl cyclase inhibitor, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), and the PKG inhibitors, KT5823, Rp-8-pCPT-cGMPS, and {N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide} (H-8), on pulmonary vascular resistance. In isolated normotensive lungs, ODQ-mediated inhibition of soluble guanylyl cyclase augmented hypoxic pulmonary vasoconstriction, whereas the PKG inhibitors had no effect. Despite the marked differences in the physiological effect, ODQ and Rp-8-pCPT-cGMPS inhibited PKG activity to a similar degree as determined by a back-phosphorylation assay showing decreased PKG-mediated phosphorylation of serine 1755 on the D-myo-inositol 1,4,5-trisphosphate receptor. In hypertensive lungs, inhibition of soluble guanylyl cyclase by ODQ increased perfusion pressure by 101 ± 20% (P < 0.05), an increase similar to that seen with inhibition of NO synthase (NOS), confirming an essential role for cGMP. In contrast, KT5823, Rp-8-pCPT-cGMPS, and H-8 (used in doses 5- to 100-fold in excess of their reported inhibitory concentrations for PKG) caused only a small increase in baseline perfusion pressure (14 ± 2%, P = not significant from vehicle control). Effectiveness of PKG inhibition in the hypertensive lungs was also confirmed with the back-phosphorylation assay. These studies suggest that whereas NO-mediated modulation of vascular tone in the normotensive and hypertensive pulmonary circulation is dependent on cGMP formation, activation of PKG may not be essential.
hypoxic pulmonary vasoconstriction
This article has been cited by other articles:
![]() |
N. L. Jernigan, B. R. Walker, and T. C. Resta Chronic hypoxia augments protein kinase G-mediated Ca2+ desensitization in pulmonary vascular smooth muscle through inhibition of RhoA/Rho kinase signaling Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1220 - L1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Jernigan, B. R. Walker, and T. C. Resta Pulmonary PKG-1 is upregulated following chronic hypoxia Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L634 - L642. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Resta Hypoxic regulation of nitric oxide signaling in vascular smooth muscle Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L293 - L295. [Full Text] [PDF] |
||||
![]() |
D. Li, V. E. Laubach, and R. A. Johns Upregulation of lung soluble guanylate cyclase during chronic hypoxia is prevented by deletion of eNOS Am J Physiol Lung Cell Mol Physiol, August 1, 2001; 281(2): L369 - L376. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Gupta, M. D. Ober, C. Patterson, M. Al-Hassani, V. Natarajan, and C. M. Hart Nitric oxide attenuates H2O2-induced endothelial barrier dysfunction: mechanisms of protection Am J Physiol Lung Cell Mol Physiol, January 1, 2001; 280(1): L116 - L126. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hampl and J. Herget Role of Nitric Oxide in the Pathogenesis of Chronic Pulmonary Hypertension Physiol Rev, October 1, 2000; 80(4): 1337 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Dhanakoti, Y. Gao, M. Q. Nguyen, and J. U. Raj Involvement of cGMP-dependent protein kinase in the relaxation of ovine pulmonary arteries to cGMP and cAMP J Appl Physiol, May 1, 2000; 88(5): 1637 - 1642. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, N. Zhou, and R. A. Johns Soluble guanylate cyclase gene expression and localization in rat lung after exposure to hypoxia Am J Physiol Lung Cell Mol Physiol, October 1, 1999; 277(4): L841 - L847. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gao, S. Dhanakoti, J.-F. Tolsa, and J. U. Raj Role of protein kinase G in nitric oxide- and cGMP-induced relaxation of newborn ovine pulmonary veins J Appl Physiol, September 1, 1999; 87(3): 993 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Rae, M. A. Khoyi, and K. D. Keef Modulation of cholinergic neuromuscular transmission by nitric oxide in canine colonic circular smooth muscle Am J Physiol Gastrointest Liver Physiol, December 1, 1998; 275(6): G1324 - G1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Al-Mehdi, C. Song, K. Tozawa, and A. B. Fisher Ca2+- and Phosphatidylinositol 3-Kinase-dependent Nitric Oxide Generation in Lung Endothelial Cells in Situ with Ischemia J. Biol. Chem., December 15, 2000; 275(51): 39807 - 39810. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |